Non-Invasive Cardiovascular Imaging for Cardiovascular Risk Assessment in Rheumatoid Arthritis

People with rheumatoid arthritis (RA) are often under-recognised as a group with elevated risk of cardiovascular (CV) disease and increased morbidity from CV events. Standard clinical risk assessment tools, which take into account traditional CV risk factors such as smoking, diabetes, hypertension,...

Full description

Bibliographic Details
Main Authors: Erin M. Scanlon, Rekha Mankad, John M. Davis III
Format: Article
Language:English
Published: European Medical Journal 2016-07-01
Series:European Medical Journal Rheumatology
Subjects:
Online Access:http://emjreviews.com/wp-content/uploads/Non-Invasive-Cardiovascular-Imaging-for-Cardiovascular-Risk-Assessment-in-Rheumatoid-Arthritis.pdf
id doaj-8328415aacc5401abfa2cb6bf907abc3
record_format Article
spelling doaj-8328415aacc5401abfa2cb6bf907abc32020-11-24T23:35:23ZengEuropean Medical JournalEuropean Medical Journal Rheumatology2056-63952016-07-0131106113Non-Invasive Cardiovascular Imaging for Cardiovascular Risk Assessment in Rheumatoid ArthritisErin M. Scanlon0Rekha Mankad1John M. Davis III2Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA Division of Cardiology, Mayo Clinic, Rochester, Minnesota, USA Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA People with rheumatoid arthritis (RA) are often under-recognised as a group with elevated risk of cardiovascular (CV) disease and increased morbidity from CV events. Standard clinical risk assessment tools, which take into account traditional CV risk factors such as smoking, diabetes, hypertension, hyperlipidaemia, and family history do not accurately predict CV risk in patients with autoimmune rheumatic disorders; therefore, there is an unmet need for other methods to assess their risk. Non-invasive CV imaging is evolving as a novel clinical tool to determine subclinical atherosclerotic coronary artery disease in patients with RA. Non-invasive imaging studies, such as tests of endothelial function (i.e. reactive hyperaemia index and flow-mediated dilation) and arterial stiffness (i.e. pulse-wave velocity), have been identified as a potential means for providing accurate assessment of early CV risk in the general population and are evolving in their utility for patients with RA. These types of non-invasive imaging have the potential to eliminate the current use of invasive assessments for identification of precursors to coronary artery disease, such as coronary angiography for early endothelial cell dysfunction. By combining the expertise of subspecialists in cardio-rheumatology clinics, the expectation is to pre-emptively identify RA patients with early coronary artery disease, allowing early modification of risk factors through either medical management or lifestyle modification.http://emjreviews.com/wp-content/uploads/Non-Invasive-Cardiovascular-Imaging-for-Cardiovascular-Risk-Assessment-in-Rheumatoid-Arthritis.pdfaortic pulse-wave velocity (aPWV)Cardio-rheumatologyendothelial cellsflow-mediated dilation (FMD)
collection DOAJ
language English
format Article
sources DOAJ
author Erin M. Scanlon
Rekha Mankad
John M. Davis III
spellingShingle Erin M. Scanlon
Rekha Mankad
John M. Davis III
Non-Invasive Cardiovascular Imaging for Cardiovascular Risk Assessment in Rheumatoid Arthritis
European Medical Journal Rheumatology
aortic pulse-wave velocity (aPWV)
Cardio-rheumatology
endothelial cells
flow-mediated dilation (FMD)
author_facet Erin M. Scanlon
Rekha Mankad
John M. Davis III
author_sort Erin M. Scanlon
title Non-Invasive Cardiovascular Imaging for Cardiovascular Risk Assessment in Rheumatoid Arthritis
title_short Non-Invasive Cardiovascular Imaging for Cardiovascular Risk Assessment in Rheumatoid Arthritis
title_full Non-Invasive Cardiovascular Imaging for Cardiovascular Risk Assessment in Rheumatoid Arthritis
title_fullStr Non-Invasive Cardiovascular Imaging for Cardiovascular Risk Assessment in Rheumatoid Arthritis
title_full_unstemmed Non-Invasive Cardiovascular Imaging for Cardiovascular Risk Assessment in Rheumatoid Arthritis
title_sort non-invasive cardiovascular imaging for cardiovascular risk assessment in rheumatoid arthritis
publisher European Medical Journal
series European Medical Journal Rheumatology
issn 2056-6395
publishDate 2016-07-01
description People with rheumatoid arthritis (RA) are often under-recognised as a group with elevated risk of cardiovascular (CV) disease and increased morbidity from CV events. Standard clinical risk assessment tools, which take into account traditional CV risk factors such as smoking, diabetes, hypertension, hyperlipidaemia, and family history do not accurately predict CV risk in patients with autoimmune rheumatic disorders; therefore, there is an unmet need for other methods to assess their risk. Non-invasive CV imaging is evolving as a novel clinical tool to determine subclinical atherosclerotic coronary artery disease in patients with RA. Non-invasive imaging studies, such as tests of endothelial function (i.e. reactive hyperaemia index and flow-mediated dilation) and arterial stiffness (i.e. pulse-wave velocity), have been identified as a potential means for providing accurate assessment of early CV risk in the general population and are evolving in their utility for patients with RA. These types of non-invasive imaging have the potential to eliminate the current use of invasive assessments for identification of precursors to coronary artery disease, such as coronary angiography for early endothelial cell dysfunction. By combining the expertise of subspecialists in cardio-rheumatology clinics, the expectation is to pre-emptively identify RA patients with early coronary artery disease, allowing early modification of risk factors through either medical management or lifestyle modification.
topic aortic pulse-wave velocity (aPWV)
Cardio-rheumatology
endothelial cells
flow-mediated dilation (FMD)
url http://emjreviews.com/wp-content/uploads/Non-Invasive-Cardiovascular-Imaging-for-Cardiovascular-Risk-Assessment-in-Rheumatoid-Arthritis.pdf
work_keys_str_mv AT erinmscanlon noninvasivecardiovascularimagingforcardiovascularriskassessmentinrheumatoidarthritis
AT rekhamankad noninvasivecardiovascularimagingforcardiovascularriskassessmentinrheumatoidarthritis
AT johnmdavisiii noninvasivecardiovascularimagingforcardiovascularriskassessmentinrheumatoidarthritis
_version_ 1725526449297817600